A nidus, crystalluria and aggregation: key ingredients for stone enlargement

Area of Science:

• Biochemistry
• Urology
• Materials Science

Background:

• In vitro studies of calcium oxalate (CaOx) stone formation often use crystallization models.
• Both healthy individuals and stone formers exhibit crystalluria, highlighting the complexity of stone development.

Purpose of the Study:

• To establish a robust in vitro model for studying calcium oxalate stone growth.
• To investigate the influence of CaOx crystallization kinetics and varying calcium and oxalate concentrations on stone growth.

Main Methods:

• A mixed suspension, mixed product removal system (MSMPR) was employed for in vitro stone growth.
• Six stones were subjected to standard Ca and Ox concentrations, while six received variable concentrations.
• Stone mass was monitored over 5-7 weeks to assess growth dynamics.

Main Results:

• CaOx stone growth requires sufficient calcium and oxalate concentrations; reduced inputs halted growth.
• Stone growth rate correlated positively with crystal suspension numbers and nucleation rates.
• Stone growth rate correlated negatively with crystal growth rates.

Conclusions:

• Crystal aggregation from suspension is the primary mechanism driving calcium oxalate stone enlargement.
• The MSMPR model provides a robust platform for studying in vitro urolithiasis.
• Understanding these kinetics is crucial for developing effective treatments for kidney stones.